Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-13-000166

President & CEO sold 3,000 shares at $39.88 ($119,647)

  • President & CEO acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CONCANNON BRIAN · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-10-01 Exercise or conversion : show line 1 in the form +3,000 $13.05 $39,158 118,798 D
2013-10-01 Sale : show line 2 in the form −3,000 $39.88 $119,647 115,798 D
Open-market sales · 3,000 sh · avg $39.88 · $119,647

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2013-10-01 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) −3,000 $39.88 $119,647 $13.05 2014-05-05 3,000 12,000 D
Loading xslF345X03/edgardoc.xml…